![]() |
| By Dr.Muneeb Faraaz |
A little known pharmaceutical company of Hyderabad has again lit the fuse to the volatile issue of access to medicines and patent rights in India. Lee Pharma has applied for a compulsory licence to produce a cheaper version of a patented medicine to treat diabetes, a move that is likely to set off a furious global debate on the contested aspects of India’s patent law.






